AHSG and type 2 diabetes mellitus: Deletion of Fetuin-A improves insulin resistance and dyslipidemia and enhances glucose clearance in mice [192], whereas with genetic variants in humans, Fetuin-A has been associated with type 2 diabetes [193] and is linked with insulin action in adipocytes [194].